Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade

Urologic Oncology
Dan LeiboviciLouis L Pisters

Abstract

Biochemical recurrence after either radical prostatectomy or radiation therapy of prostate cancer will develop in an estimated 50,000 U.S. men. Salvage therapy has the potential of curing an isolated local recurrence of prostate cancer, however, this comes at the cost of potential morbidity. Salvage surgery after primary radiotherapy is technically demanding, and surgical expertise is necessary to optimize treatment outcomes while minimizing the inherent risks of the operation. Over the last decade, we have developed a substantial experience in salvage surgery for locally recurrent prostate cancer, and have developed key technical points and innovations that include primary closure of the bladder neck, bladder augmentation, and catheterizable urinary reconstruction using a Monti or Mitrofanoff procedure as a method of reducing the risks of postoperative urinary incontinence. We hope this review will provide the surgical oncologist and urologist with the important considerations that must be considered in salvage surgery. In addition, we discuss the importance and surgical details of using a well-vascularized rectus flap as a method of reducing perioperative morbidity.

References

Dec 1, 1991·Urology·A W Mazur, I M Thompson
Apr 1, 1980·Archives of Surgery·R S HartzT W Shields
Nov 1, 1995·Archives of Otolaryngology--head & Neck Surgery·G L ClaymanH Goepfert
Jun 1, 1995·Plastic and Reconstructive Surgery·J A RubinT R Stevenson
Feb 12, 1997·JAMA : the Journal of the American Medical Association·J E JohanssonH O Adami
Mar 1, 1997·The Journal of Urology·L L PistersR J Babaian
Apr 14, 1999·The British Journal of Surgery·E RadiceL Gunderson
May 8, 2000·The Journal of Urology·J W Moul
Oct 31, 2001·Seminars in Oncology·N N Senzer
Jul 20, 2002·The Journal of Urology·Jackson E FowlerWilliam L Duncan
Nov 9, 2002·Hernia : the Journal of Hernias and Abdominal Wall Surgery·Alaa S O Abdul Jabbar
Sep 11, 2003·The Lancet Oncology·Helen B StoneWilliam H McBride
Oct 22, 2003·Journal of Cancer Research and Clinical Oncology·Aristotelis G AnastasiadisAaron E Katz
Sep 3, 2004·Current Treatment Options in Oncology·Andrew J StephensonJames A Eastham
Jan 12, 2005·The Journal of Urology·Naji J ToumaJoseph L Chin
Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Carlos VargasAlvaro A Martinez
Apr 12, 2005·Cancer·Dan LeiboviciLouis L Pisters

❮ Previous
Next ❯

Citations

Apr 18, 2009·Current Urology Reports·Jared M Cox, J Erik Busby
Feb 21, 2008·Der Urologe. Ausg. A·S H StübingerR Galalae
Oct 12, 2012·World Journal of Urology·Stephen J Ramey, David T Marshall
Jan 27, 2010·Cancer Treatment Reviews·Christian Boukaram, Jean-Michel Hannoun-Levi
Dec 10, 2008·Current Problems in Cancer·John F WardLouis L Pisters
Jul 9, 2009·BJU International·Masaki KimuraThomas J Polascik
Feb 13, 2010·BJU International·David LevyJ Stephen Jones
Aug 6, 2009·Journal of Endourology·Carlos Nuñez-MoraPedro M Cabrera-Castillo
Mar 18, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Lino M SawickiHubertus Hautzel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.